Here are two no-brainer healthcare stocks to buy with $500 right now. First, Vertex enjoys a monopoly. Only five approved therapies restore the CFTR protein whose mutations cause cystic fibrosis (CF).
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...
Zacks Investment Research on MSN5d
Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase. VRTX ...
Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback